• Department of Anesthesiology, Shengjing Hospital, China Medical University, Shenyang 110004, China;
WU Xiuying, Email: wuxiuying0415@163.com
Export PDF Favorites Scan Get Citation

Objective  To carry out a meta-analysis to evaluate the efficacy and safety of dexmedetomidine in comparison with midazolam as preoperative drug.
Methods  All randomized controlled trials (RCTs) about dexmedetomidine as preoperative drug compared with midazolam were identified. Meta analysis was performed by using the statistical software RevMan 4.2.10 on the basis of strict quality evaluation.
Results  Thirteen RCTs involving 806 patients were included. The results of meta analyses showed that dexmedetomidine was better than midazolam in decreasing perioperative blood pressure and heart rate, decreasing dosage of anesthetics, shortening of emergence time, and decreasing the occurrence of agitation, while the occurrence of perioperative hypotention and bradycardia of dexmedetomidine was much more than midazolam. The statistical outcomes showed that there were no differences between the two drugs in the satisfactory score, postoperative sedation score, the number of people needing analgesia, and occurrence of nausea and vomitting.
Conclusion  Significant advantages in favour of dexmedetomidine as preoperative drug are observed. Dexmedetomidine is safe except for more incidences of hypotension and bradycardia.

Citation: SUN Jiehao,HAN Ning,WU Xiuying. Dexmedetomidine versus Midazolam in Anesthetic Preoperative Administration: A Meta-analysis. Chinese Journal of Evidence-Based Medicine, 2009, 09(11): 1231-1237. doi: 10.7507/1672-2531.20090221 Copy

  • Previous Article

    Effect of Local Application of Metronidazole with Scaling and Root Planing: A Meta-Analysis
  • Next Article

    Evidence-Based Treatment of Hepatitis C after Kidney Transplantation with Combined Interferon-α and Ribavirin